Found 27 results
Author Title Type [ Year(Asc)]
Filters: Author is Dally, L  [Clear All Filters]
2014
Karita, E., Anzala, O., Gazzard, B., Bergin, P., Nyombayire, J., Omosa, G., et al.. (2014). Clinical Safety and Immunogenicity of Two HIV Vaccines SeV-G(NP) and Ad35-GRIN in HIV-uninfected, Healthy Adult Volunteers. In HIVR4P (HIV Research for Prevention). presented at the 28/10/2014, Cape Town, South Africa. Retrieved from http://hivr4p.org/
2008
2005
G Manyonyi, O., Jaoko, W., Wakasiaka, S., Bwayo, J., Achola, N. J., Schmidt, C., et al.. (2005). Challenges Experienced By the Clinical Team During The Conduct of HIV Vaccine Clinical Trials in Kenya. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.
Peters, B., Jaoko, W., Anzala, O., Judges, L., G Manyonyi, O., Sharp, A., et al.. (2005). Phase 2A Dose and Route Study of a DNA Prime MVA Boost Vaccine Candidate. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.
Vardas, E., Pantaleo, G., Bart, P. A., Robinson, A., Pieterse, C., Thomas, R., et al.. (2005). Safety and Immunogenicity of MVA.HIVA by 3 Different Routes. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.